Mesenchymal Stem Cells from Different Sources Show Distinct Therapeutic Effects in Hyperoxia-Induced Bronchopulmonary Dysplasia in Rats

Researchers evaluated intratracheal MSCs as an approach to treat an hyperoxia-induced bronchopulmonary dysplasia animal model and compared the therapeutic effects between amniotic fluid-, umbilical cord- and bone marrow-MSCs.